<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01967277</url>
  </required_header>
  <id_info>
    <org_study_id>USC650</org_study_id>
    <nct_id>NCT01967277</nct_id>
  </id_info>
  <brief_title>A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy</brief_title>
  <official_title>A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Capillus, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Capillus, LLC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will acquire data on hair growth of the head that is the result of treatment with
      a non-heat generating, laser product. This data will come from counting of terminal hairs
      before treatment begins and after treatment is completed. The treatment regime is every other
      day for 16 weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the efficacy of Low Level Laser Therapy product that
      is configured in the novel design of a baseball cap, for promoting hair growth in females
      diagnosed with genetic hair loss/female pattern hair loss.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage Increase in Terminal Hair Counts From Pre-Treatment, Baseline for Active Test Subjects Over the Placebo Test Subjects.</measure>
    <time_frame>baseline and 17 weeks</time_frame>
    <description>At baseline, a 25 mm area of treatment was trimmed of hair (to 3mm) at the vertex of the scalp and photographs were taken, terminal hairs were counted.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Absolute Increase in Terminal Hair Counts From Pre-Treatment, Baseline for Active Test Subjects Over the Placebo Test Subjects.</measure>
    <time_frame>baseline and 17 weeks</time_frame>
    <description>At baseline, a 25 mm area of treatment was trimmed of hair (to 3mm) at the vertex of the scalp and photographs were taken, terminal hairs were counted.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Androgenetic Alopecia</condition>
  <arm_group>
    <arm_group_label>Incandescent red light source</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A red, incandescent light source replaces all laser output. The treatment sessions are self-administered at home, every other day, for 16 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Handi-Dome Laser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Study subjects self-administer actual laser treatments, at home, every other day, for 16 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Handi-Dome Laser</intervention_name>
    <description>One, 30 minute treatment, every other day for 16 weeks.</description>
    <arm_group_label>Handi-Dome Laser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Incandescent red light source.</intervention_name>
    <description>One, 30 minute treatment, every other day for 16 weeks.</description>
    <arm_group_label>Incandescent red light source</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Diagnosis of Androgenetic Alopecia / Female Pattern Hair Loss Fitzpatrick skin phototypes
        of I - IV Ludwig-Savin Hair Loss scale I - II In overall good health as determined by the
        physician investigator Active hair loss within the last 12 months Willingness to refrain
        from using all other hair growth products or treatments -

        Exclusion Criteria:

        Photosensitivity to the specific wavelength of light - 650 nanometers. Malignancy in the
        target treatment area Other forms of alopecia of the head Past medical history of a
        collagen-vascular disease, thyroid disease or other cutaneous or systemic disease that
        seriously affects the scalp.

        In willingness to remove hair replacement products during the 16 weeks of therapy.

        Using any medications deemed to inhibit hair growth as determined by the physician
        investigator.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raymond R. Blanche, BA</last_name>
    <role>Study Director</role>
    <affiliation>NST Consulting, LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bodian Dermatology</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <zip>11021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Aesthetic Dermatology</name>
      <address>
        <city>Woodbury</city>
        <state>New York</state>
        <zip>11797</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2013</study_first_submitted>
  <study_first_submitted_qc>October 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2013</study_first_posted>
  <results_first_submitted>May 5, 2015</results_first_submitted>
  <results_first_submitted_qc>May 5, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 6, 2015</results_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alopecia</mesh_term>
    <mesh_term>Alopecia Areata</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Incandescent Red Light Source</title>
          <description>Placebo: A red, incandescent light source replaces all laser output. The treatment sessions are self-administered at home, every other day, for 16 weeks.
Incandescent red light source.: One, 30 minute treatment, every other day for 16 weeks.</description>
        </group>
        <group group_id="P2">
          <title>Handi-Dome Laser</title>
          <description>Active Device: Study subjects self-administer actual laser treatments, at home, every other day, for 16 weeks.
Handi-Dome Laser: One, 30 minute treatment, every other day for 16 weeks.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Unrelated illness</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Incandescent Red Light Source</title>
          <description>Placebo: A red, incandescent light source replaces all laser output. The treatment sessions are self-administered at home, every other day, for 16 weeks.
Incandescent red light source.: One, 30 minute treatment, every other day for 16 weeks.</description>
        </group>
        <group group_id="B2">
          <title>Handi-Dome Laser</title>
          <description>Active Device: Study subjects self-administer actual laser treatments, at home, every other day, for 16 weeks.
Handi-Dome Laser: One, 30 minute treatment, every other day for 16 weeks.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="22"/>
            <count group_id="B3" value="44"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49" lower_limit="28" upper_limit="60"/>
                    <measurement group_id="B2" value="49.5" lower_limit="28" upper_limit="58"/>
                    <measurement group_id="B3" value="49" lower_limit="28" upper_limit="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage Increase in Terminal Hair Counts From Pre-Treatment, Baseline for Active Test Subjects Over the Placebo Test Subjects.</title>
        <description>At baseline, a 25 mm area of treatment was trimmed of hair (to 3mm) at the vertex of the scalp and photographs were taken, terminal hairs were counted.</description>
        <time_frame>baseline and 17 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Incandescent Red Light Source</title>
            <description>Placebo: A red, incandescent light source replaces all laser output. The treatment sessions are self-administered at home, every other day, for 16 weeks.
Incandescent red light source.: One, 30 minute treatment, every other day for 16 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Handi-Dome Laser</title>
            <description>Active Device: Study subjects self-administer actual laser treatments, at home, every other day, for 16 weeks.
Handi-Dome Laser: One, 30 minute treatment, every other day for 16 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Increase in Terminal Hair Counts From Pre-Treatment, Baseline for Active Test Subjects Over the Placebo Test Subjects.</title>
          <description>At baseline, a 25 mm area of treatment was trimmed of hair (to 3mm) at the vertex of the scalp and photographs were taken, terminal hairs were counted.</description>
          <units>percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.48" spread="13.76"/>
                    <measurement group_id="O2" value="63.67" spread="50.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>H0: µL ≤ µs Versus Ha: µL &gt; µs</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Absolute Increase in Terminal Hair Counts From Pre-Treatment, Baseline for Active Test Subjects Over the Placebo Test Subjects.</title>
        <description>At baseline, a 25 mm area of treatment was trimmed of hair (to 3mm) at the vertex of the scalp and photographs were taken, terminal hairs were counted.</description>
        <time_frame>baseline and 17 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Incandescent Red Light Source</title>
            <description>Placebo: A red, incandescent light source replaces all laser output. The treatment sessions are self-administered at home, every other day, for 16 weeks.
Incandescent red light source.: One, 30 minute treatment, every other day for 16 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Handi-Dome Laser</title>
            <description>Active Device: Study subjects self-administer actual laser treatments, at home, every other day, for 16 weeks.
Handi-Dome Laser: One, 30 minute treatment, every other day for 16 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Absolute Increase in Terminal Hair Counts From Pre-Treatment, Baseline for Active Test Subjects Over the Placebo Test Subjects.</title>
          <description>At baseline, a 25 mm area of treatment was trimmed of hair (to 3mm) at the vertex of the scalp and photographs were taken, terminal hairs were counted.</description>
          <units>terminal hairs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hair count, baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="216.9" spread="109.1"/>
                    <measurement group_id="O2" value="189.3" spread="85.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hair count, post treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="235.3" spread="105.8"/>
                    <measurement group_id="O2" value="268.3" spread="117.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hair count, difference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.5" spread="24.4"/>
                    <measurement group_id="O2" value="89.9" spread="63.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Incandescent Red Light Source</title>
          <description>Placebo: A red, incandescent light source replaces all laser output. The treatment sessions are self-administered at home, every other day, for 16 weeks.
Incandescent red light source.: One, 30 minute treatment, every other day for 16 weeks.</description>
        </group>
        <group group_id="E2">
          <title>Handi-Dome Laser</title>
          <description>Active Device: Study subjects self-administer actual laser treatments, at home, every other day, for 16 weeks.
Handi-Dome Laser: One, 30 minute treatment, every other day for 16 weeks.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>PI may not disclose the results of the trial.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Patricia Schnoor</name_or_title>
      <organization>Capillus LLC</organization>
      <phone>7868881874</phone>
      <email>pschnoor@capillus.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

